v3.26.1
Borrowings (Tables)
 6 Months Ended
Jun. 30, 2026
Borrowings [abstract]  
Schedule of composition of borrowings
Borrowings of the Group at period-end include the following:
 in € thousand June 30, 2026December 31, 2025
NON-CURRENT
Borrowings and other loans165,631 161,261 
CURRENT
Borrowing and other loans18,428 17,905 
TOTAL BORROWINGS184,060 179,167 
Schedule of maturity analysis of non-current borrowings
The maturity of the borrowings is as follows:
in € thousandJune 30, 2026December 31, 2025
Between 1 and 3 years29,581 28,715 
Between 3 and 5 years135,198 131,953 
Over 5 years852 594 
NON-CURRENT BORROWINGS165,631 161,261 
Current borrowings18,428 17,905 
TOTAL BORROWINGS184,060 179,167 
Schedule of borrowings by denominated currency
The carrying amounts of the Group’s borrowings are denominated in the following currencies:
in € thousandJune 30, 2026December 31, 2025
Borrowings denominated in EUR3,144 3,144 
Borrowings denominated in USD180,915 176,022 
TOTAL BORROWINGS184,060 179,167 
Schedule of reconciliation of loan
The Pharmakon Loan Agreement and the previous D&O Loan Agreement, which the Pharmakon Loan superseded and fully replaced during the fourth quarter of 2025, developed as follows:
in € thousandJune 30, 2026December 31, 2025
BALANCE AS AT JANUARY 1173,407 180,841 
Proceeds of issue— 182,979 
Transaction costs— (10,130)
Principal repayment— (170,213)
Accrued interest9,721 28,403 
Payment of interest(8,505)(17,558)
Exchange rate difference5,428 (20,916)
BALANCE AS AT CLOSING DATE180,052 173,407 
Less: non-current portion(162,833)(156,710)
CURRENT PORTION17,218 16,697